People · Operator
Named in public records as an officer, director or promoter · active 2014–2026 · Other Health Care, Other Technology, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuMoDx Molecular, Inc. | — | Other Health Care | Series B | $54.8M | $444.0M | 2014 |
| Protenus, Inc | — | Other Technology | Series B | $47.7M | $359.6M | 2016 |
| Rhino HealthTech, Inc. | — | Healthtech | Series A | $44.7M | $31.6M | 2020 |
| PhysIQ, Inc. | — | Other Health Care | Series A | $20.1M | $121.1M | 2016 |
| Phantom Neuro Inc. | — | Biotechnology | Series A | $15.4M | $45.7M | 2025 |
| Metame Health Inc. | — | Healthtech | Seed | $4.2M | $730K | 2023 |
Edward Michael at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward Michael on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Lord | 2 | 5 |
| Jeffrey Williams | 1 | 10 |
| Jon Lim | 1 | 9 |
| Jared Kesselheim | 1 | 7 |
| Jan Garfinkle | 1 | 7 |
| William Burkoth | 1 | 5 |
| Nicole Walker | 1 | 4 |
| James Burgum | 1 | 4 |
| Daniel Bernstein | 1 | 4 |
| Sam Brasch | 1 | 4 |
| Robert Lynch | 1 | 3 |
| Harry Totonis | 1 | 3 |
| Zafi Avnur | 1 | 2 |
| Michele Kang | 1 | 2 |
| Sundaresh Brahmasandra | 1 | 2 |
| Connor Glass | 1 | 1 |
| D.A. Wallach | 1 | 1 |
| Timothy Rudolphi | 1 | 1 |
| Kenneth D. Greisman | 1 | 1 |
| Troy Hamilton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.